Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Guidelines for Nursing Documentation II01:26

Guidelines for Nursing Documentation II

1.6K
Effective documentation is an integral part of nursing practice. Here are some essential guidelines to follow when documenting patient care:
Timely documentation is crucial to ensure continuity of care for patients. Any delays in recording or reporting medical information can result in medical errors and even adverse patient outcomes. From medication administration to diagnostic test results, every detail must be accurately and promptly documented to provide the best possible care for patients.
1.6K
Legal Guidelines for Documentation01:06

Legal Guidelines for Documentation

2.1K
The legal guidelines for nursing documentation are essential for ensuring accurate, professional, and ethical recording of patient care. The guidelines are discussed here:
2.1K
Guidelines for Sketching a Curve01:23

Guidelines for Sketching a Curve

112
Curve sketching is a systematic method for understanding the overall behavior of a function by analyzing its key mathematical features. A function defines a curve on the coordinate plane, where the horizontal axis represents the input variable and the vertical axis represents the output. The process begins by determining the domain, which specifies the set of input values for which the function is defined and establishes the horizontal extent of the graph.Intercepts with the horizontal and...
112
Guidelines for Writing Outcome01:11

Guidelines for Writing Outcome

3.7K
When developing expected outcomes for a patient care plan, the nurse should adhere to the following recommendations:
Patient outcomes reflect the patient's response to the goal rather than what the nurse aims to achieve. Terminology should be observable and measurable to avoid the reader's interpretation. The desired outcome should be realistic and achievable in the designated care timeframe. Expected outcomes should align with adjunctive therapies. The outcome should enhance care...
3.7K
Guidelines for Nursing Documentation I01:30

Guidelines for Nursing Documentation I

1.8K
Quality documentation and reporting share essential characteristics that ensure they are practical and valuable resources for those who use them. These characteristics are:
Factual:  
The following points emphasize the significance of upholding accurate and unbiased documentation in healthcare.
1.8K
Guidelines For Measuring Vital Signs01:19

Guidelines For Measuring Vital Signs

2.8K
Following these guidelines can help nurses accurately measure vital signs, assess changes in patient conditions, and provide timely treatment when necessary. Adhering closely to the guidelines ensures the accuracy and reliability of the results.
Before taking a patient's vital signs, a nurse would consider and assess the patient's comfort level and ensure appropriate equipment is available.
2.8K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

ESR1 methylation and ESR1 mutations in circulating tumor cells (CTCs) and paired plasma-cfDNA of advanced breast cancer patients: A feasibility proof-of-concept study.

Molecular oncology·2026
Same author

The global cancer crisis: a review of growing burden, deepening inequality and initiatives for prevention and early detection.

Ecancermedicalscience·2026
Same author

Dual-positive CTCs in patients with advanced breast cancer show metastatic potential and prognostic value.

Science translational medicine·2026
Same author

Functional dysconnectivity in breast cancer patients undergoing hormone therapy.

Journal of clinical and experimental neuropsychology·2026
Same author

Multiscale profiling of tyrosine kinase inhibitor cardiotoxicity reveals mechanosensitive ion channel PIEZO1 as cardioprotective.

Science translational medicine·2025
Same author

USP22 drives tumor immune evasion and checkpoint blockade resistance through EZH2-mediated epigenetic silencing of MHC-I.

The Journal of clinical investigation·2025
Same journal

Genetics-Supported Mainstream Testing Improves Access and Efficiency for Patients With Breast Cancer.

Journal of the National Comprehensive Cancer Network : JNCCN·2026
Same journal

Measuring Equitable Care Delivery: Insights From the Health Equity Report Card (HERC) Pilot in Academic Cancer Centers.

Journal of the National Comprehensive Cancer Network : JNCCN·2026
Same journal

A Virtual Reality Psychosocial Intervention for Patients Undergoing Bone Marrow Transplantation (BMT-VR): Pilot Randomized Clinical Trial.

Journal of the National Comprehensive Cancer Network : JNCCN·2026
Same journal

Nationwide Trends in Colorectal Cancer Screening by the End of the COVID-19 Pandemic: Racial/Ethnic Differences and Opportunities.

Journal of the National Comprehensive Cancer Network : JNCCN·2026
Same journal

Evaluation of the Impact of Adjuvant Immunotherapy in Merkel Cell Carcinoma.

Journal of the National Comprehensive Cancer Network : JNCCN·2026
Same journal

Payers' Views on Insurance Coverage for Confirmatory Diagnostics After a Noncovered Multicancer Early Detection (MCED) Test.

Journal of the National Comprehensive Cancer Network : JNCCN·2026
See all related articles

Related Experiment Video

Updated: Jan 24, 2026

Studying Triple Negative Breast Cancer Using Orthotopic Breast Cancer Model
09:29

Studying Triple Negative Breast Cancer Using Orthotopic Breast Cancer Model

Published on: March 20, 2020

18.8K

NCCN Guidelines Updates: Breast Cancer.

Melinda L Telli, William J Gradishar, John H Ward

    Journal of the National Comprehensive Cancer Network : JNCCN
    |May 23, 2019
    PubMed
    Summary
    This summary is machine-generated.

    Precision medicine in breast cancer is advancing with genetic tests like the 21-gene recurrence score. New guidelines refine treatment for early and metastatic breast cancer, including ovarian suppression and immunotherapy.

    More Related Videos

    Orthotopic Transplantation of Breast Tumors as Preclinical Models for Breast Cancer
    07:45

    Orthotopic Transplantation of Breast Tumors as Preclinical Models for Breast Cancer

    Published on: May 18, 2020

    6.9K
    Modeling Breast Cancer in Human Breast Tissue using a Microphysiological System
    10:51

    Modeling Breast Cancer in Human Breast Tissue using a Microphysiological System

    Published on: April 23, 2021

    4.6K

    Related Experiment Videos

    Last Updated: Jan 24, 2026

    Studying Triple Negative Breast Cancer Using Orthotopic Breast Cancer Model
    09:29

    Studying Triple Negative Breast Cancer Using Orthotopic Breast Cancer Model

    Published on: March 20, 2020

    18.8K
    Orthotopic Transplantation of Breast Tumors as Preclinical Models for Breast Cancer
    07:45

    Orthotopic Transplantation of Breast Tumors as Preclinical Models for Breast Cancer

    Published on: May 18, 2020

    6.9K
    Modeling Breast Cancer in Human Breast Tissue using a Microphysiological System
    10:51

    Modeling Breast Cancer in Human Breast Tissue using a Microphysiological System

    Published on: April 23, 2021

    4.6K

    Area of Science:

    • Oncology
    • Genomics
    • Precision Medicine

    Background:

    • Molecular testing advances precision medicine.
    • The TAILORx trial refined the use of the 21-gene recurrence score for breast cancer treatment decisions.
    • NCCN Guidelines for Breast Cancer incorporate these advancements.

    Purpose of the Study:

    • To explore the clinical applications of the TAILORx trial.
    • To refine the management algorithm for the axilla in early breast cancer.
    • To update recommendations for ovarian suppression and metastatic breast cancer treatment.

    Main Methods:

    • Analysis of the TAILORx trial data.
    • Updated analysis of the SOFT and TEXT pivotal trials.
    • Review of clinical evidence for lymph node involvement.

    Main Results:

    • The 21-gene recurrence score helps assign patients to endocrine therapy or chemotherapy.
    • Ovarian suppression is validated as optimal for higher-risk premenopausal women.
    • CDK4/6 inhibitors are reinforced as preferred agents for metastatic breast cancer.

    Conclusions:

    • NCCN Guidelines for Breast Cancer reflect refined treatment strategies based on molecular testing and trial data.
    • Treatment decisions for early and metastatic breast cancer are increasingly personalized.
    • Immunotherapy is a new option for triple-negative breast cancer.